hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. (Q53581949)

15 May 2018

https://doi.org/10.1074/jbc.W120.015698

1 reference

29 December 2023

http://retractionwatch.com/?s=%22Xuetao+Cao%22

title

hPEBP4 resists TRAIL-induced apoptosis of human prostate cancer cells by activating Akt and deactivating ERK1/2 pathways. (English)

1 reference

15 May 2018

1 reference

6

0 references

author name string

Hongzhe Li

1

1 reference

15 May 2018

Xiaojian Wang

2

1 reference

15 May 2018

Nan Li

3

1 reference

15 May 2018

Jianming Qiu

4

1 reference

15 May 2018

Yuanyuan Zhang

5

1 reference

15 May 2018

Xuetao Cao

6

1 reference

15 May 2018

language of work or name

English

0 references

publication date

18 December 2006

1 reference

15 May 2018

https://www.jbc.org/article/S0021-9258(17)50025-3/fulltext

1 reference

6 June 2021

published in

Journal of Biological Chemistry

1 reference

15 May 2018

volume

282

1 reference

15 May 2018

issue

7

1 reference

15 May 2018

page(s)

4943-4950

1 reference

15 May 2018

Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Translation inhibitors sensitize prostate cancer cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by activating c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

A novel human phosphatidylethanolamine-binding protein resists tumor necrosis factor alpha-induced apoptosis by inhibiting mitogen-activated protein kinase pathway activation and phosphatidylethanolamine externalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Sensitization of TRAIL-resistant cells by inhibition of heat shock protein 90 with low-dose geldanamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Death receptor-induced cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

TRAIL, caspases and maturation of normal and leukemic myeloid precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Iron chelation-induced senescence-like growth arrest in hepatocyte cell lines: association of transforming growth factor beta1 (TGF-beta1)-mediated p27Kip1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Chloramphenicol-induced mitochondrial stress increases p21 expression and prevents cell apoptosis through a p21-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

PI3K is required for insulin-stimulated but not EGF-stimulated ERK1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chloro-2-methylellipticinium acetate (CMEP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M609494200

Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer

21 January 2018

1 reference

https://opencitations.net/index/api/v1/references/10.1074/JBC.M609494200

Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1074/JBC.M609494200

Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1074/JBC.M609494200

TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid

9 February 2024

1 reference

https://opencitations.net/index/api/v1/references/10.1074/JBC.M609494200

9 February 2024

Identifiers

DOI

10.1074/JBC.M609494200

1 reference

15 May 2018

1 reference

15 May 2018